| VU University Medical Center Amsterdam | |
|---|---|
| Stichting VU-VUmc | |
 | |
  Location in the Netherlands | |
| Geography | |
| Location | De Boelelaan 1117, 1081 HV Amsterdam, Netherlands |
| Coordinates | 52°20′04″N 4°51′36″E / 52.33444°N 4.86000°E |
| Organisation | |
| Funding | Government hospital |
| Type | Teaching |
| Affiliated university | Vrije Universiteit Amsterdam |
| Services | |
| Emergency department | Yes, Level I Trauma Center |
| Beds | 733 |
| Helipad | Yes |
| History | |
| Opened | 1964 (as the Academic Hospital of the Vrije Universiteit)[1] |
| Links | |
| Website | www |
| Lists | Hospitals in Netherlands |
VU University Medical Center Amsterdam (Dutch: VU Medisch Centrum or VUmc) is the university hospital affiliated with the Vrije Universiteit Amsterdam. It is rated one of the best academic medical centers in the country in terms of patient care[2][3] and research.[4] It is located next to Amsterdam's A10 ringway in the southwestern part of the city, next to the campus of the Vrije Universiteit and close to Schiphol airport.
On 30 October 2015, researchers at the VUmc Cancer Center Amsterdam reported developing a blood test that, from a single drop of blood, can diagnose cancer with a probability of 97%, and about 6-8% probability of a false diagnosis, in healthy patients.[5][6] In October 2015 the VUmc got the first MRIdian system in Europe, currently the most advanced radiation therapy system to treat tumors, because the system has a built-in MRI scanner to aim the radiation optimally.[7]
- ^ "Dedicated care". VUmc. 2001-01-01. Retrieved 2015-09-27.
- ^ "Het beste academische ziekenhuis van Nederland - Wegwijs". Retrieved 25 September 2015.
- ^ "Nieuws, achtergronden en opinie - Elsevier.nl". Elsevier. Retrieved 25 September 2015.
- ^ "De Nederlandse universitair medische centra" (PDF). Nfu.nl. Retrieved 2015-09-27.
- ^ Simons, Warren (30 October 2015). "Single Drop Of Blood Will Soon Be Enough To Diagnose Most Types of Cancer". The Latest News. Retrieved 6 November 2015.
- ^ Best, Myron G.; et al. (9 November 2015). "RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics". Cancer Cell. 28 (5): 666–676. doi:10.1016/j.ccell.2015.09.018. PMC 4644263. PMID 26525104.
- ^ "First MRIdian System Installed in Europe at VU University Medical Center of Amsterdam". ViewRay, Inc.